Viscosupplementation Brand FAQs: Comparing HA Injection Options
Get answers to common questions about hyaluronic acid injection brands. Compare Synvisc, Monovisc, Euflexxa, and other viscosupplementation options for knee pain.
With several FDA-approved hyaluronic acid injection brands available, choosing the right one can be confusing. This FAQ compares the major viscosupplementation brands, explains the differences between single-injection and series products, and helps you understand what factors matter most when selecting an HA injection for knee pain.
Have more questions? Explore our hyaluronic acid injections guide or compare HA injections to other treatments.
The main FDA-approved HA injection brands include Synvisc-One and Synvisc (Sanofi), Monovisc (Zimmer Biomet), Euflexxa (Ferring), Gel-One (Zimmer Biomet), Supartz FX (Bioventus), Orthovisc (Anika), and Hyalgan (Fidia). Each differs in molecular weight, source material, injection schedule, and cost.
Learn moreSingle-injection products like Synvisc-One, Monovisc, and Gel-One deliver the full dose in one visit. Series products like Euflexxa, Supartz FX, and Hyalgan require 3-5 weekly injections. Single injections are more convenient, while series injections deliver smaller amounts over time. Research shows similar overall effectiveness for both approaches.
Both are single-injection products. Synvisc-One is avian-derived (from rooster combs) with high molecular weight. Monovisc is non-avian (produced by fermentation) and may be preferred for patients with poultry allergies. Both provide similar duration of relief. Your doctor's experience and your insurance coverage may determine which is recommended.
Euflexxa is one of the few non-avian HA products, made through bacterial fermentation rather than from rooster combs. This makes it suitable for patients with egg or poultry allergies. It requires a series of three weekly injections. Euflexxa uses bioengineered hyaluronic acid that closely matches the natural HA in your joints.
No single brand has been proven clearly superior to the others. Studies comparing brands show generally similar outcomes. The best choice depends on your specific situation: whether you prefer one injection or a series, any allergy concerns, your insurance coverage, and your doctor's experience with specific products.
Yes, many insurance plans have a preferred brand or formulary list. Medicare covers all FDA-approved HA products, but your supplemental plan may have preferences. Private insurers often designate one or two preferred brands with lower copays. Ask your insurance company which brands are covered before your appointment.
Yes, you can switch brands when you receive your next injection series (typically 6-12 months later). Some patients switch if one brand did not provide enough relief or if insurance coverage changes. Your doctor may also recommend trying a different brand if results were not satisfactory with the first one.
Consider these factors: your insurance coverage and preferred formulary, whether you have poultry or egg allergies (choose non-avian), whether you prefer one visit or multiple visits, your doctor's experience and recommendation, and cost. Your orthopedic specialist can guide you based on your specific joint condition and health history.
Avian HA is extracted from rooster combs (the red crest on a chicken's head). Non-avian HA is produced through bacterial fermentation in a lab. Both are effective for joint lubrication. The main practical difference is that non-avian products are safe for people with poultry or egg allergies. Avian products include Synvisc-One, while non-avian options include Euflexxa and Monovisc.
There are no true generic versions of HA injections because they are classified as medical devices, not drugs. However, there are multiple competing brands at different price points. Some products like Supartz FX and Hyalgan tend to be less expensive than newer single-injection products. Ask your provider about cost-effective options.
Compare Treatment Options
See how related treatments compare side by side.
Bracing & Orthotics vs Injections
Bracing and injections address joint pain through completely different mechanisms. Braces provide external support, stability, and load redistribution that protect the joint during daily activities. Injections deliver medication directly into the joint to reduce inflammation or improve lubrication. These treatments complement each other well, and most comprehensive treatment plans include both.
View comparisonCortisone Injections vs Gel Injections (Hyaluronic Acid)
Both injection types have distinct roles in knee osteoarthritis treatment. Cortisone provides fast, powerful relief but with limitations on frequency and potential cartilage concerns. Gel injections (hyaluronic acid) offer longer-lasting relief and can be safely repeated, making them preferable for ongoing management.
View comparisonEuflexxa vs Durolane
Both are safe for bird allergies. Durolane offers single-injection convenience, while Euflexxa's three-injection series may be more affordable and allows for graduated delivery.
View comparisonConservative Treatment vs Knee Replacement Surgery
Conservative treatments are the first-line approach for mild-to-moderate OA and can delay surgery by years. Surgery is appropriate for severe OA when conservative options have been exhausted.
View comparisonRelated Articles
Learn more with these related articles from our expert team.
AAOS vs OARSI: Why Guidelines Disagree on Gel Shots
Medical organizations disagree on whether to recommend hyaluronic acid injections for knee osteoarthritis. Understand why AAOS recommends against while OARSI supports them, and what this means for your treatment decisions.
blogAcupuncture for Knee Osteoarthritis: The Evidence
Discover what research says about acupuncture for knee arthritis pain. Learn about effectiveness, what to expect during treatment, and how to find a qualified practitioner.
blogKeep HA Knee Injections Covered: BCBS IL Medicare 2026
A comprehensive evidence-based report on why Blue Cross Blue Shield of Illinois should maintain Medicare Advantage coverage for viscosupplementation (HA injections) in 2026. Includes clinical efficacy data, cost-effectiveness analysis, and policy comparisons.
blogBCBS Illinois Ends Viscosupplementation Coverage in 2026: What Patients Should Do
Blue Cross Blue Shield of Illinois will stop covering HA injections for knee osteoarthritis in 2026. We examine the evidence they're ignoring, what this means for patients, and why Medicare remains stable.
Browse More FAQ Topics
Find answers to other common questions about joint pain and treatment.